Search results for "Science"
Article
Transformative Medicines Challenge FDA and Manufacturers
…ymphoblastic leukemia; this approval was followed by Yescarta (axicabtagene ciloleucel) from Gilead Sciences and Kite Pharma for broader treatment of a similar lethal condition. Spark Therapeutics’ L…
Article
From Darwin to Recombinant Fc Multimers
Before the final session, Professor Brian Smith, from Pragmedic, UK, presented the focus lecture titled "Darwin’s Medicine: How Business Models are Evolving in the Life Sciences Industry." In h…
Article
Critical Quality Attributes Challenge Biologics Development
With the advancement of knowledge in analytical sciences, protein engineering, biology, and cell-culture process, it is now possible to assess quality attributes more objectively than before. The awar…
Article
Automating Bioprocesses
BioPharm International spoke with Michalle Adkins, director of Life Sciences Consulting, and Bill Smizaski, vice-president of Global Life Sciences Operations, both at Emerson, about considerations for…
Article
Process Chromatography Selection for Downstream Processing Applications
…liporeSigma; and Peter Levison, PhD, senior marketing director of Downstream Processes at Pall Life Sciences discuss important considerations in process chromatography selection.
Separation Tec…
Article
Framing Biopharma Success in 2016
Right-sizing R&D efforts for improved returns
For the past six years, Deloitte and GlobalData analysts examined R&D results for the top 12 publicly held, research-based life-science companies (mea…
Article
Tools for Continuous Bioprocessing Development
Could perfusion microbioreactors bring more agility to biomanufacturing?
By Rajeev J. Ram
In semiconductor manufacturing, for example, a thorough understanding of process variation allows co…
Article
Biomanufacturing Outsourcing Globalization Continues
opened its Life Sciences Centre of Excellence in Shanghai, which offers biopharma process solutions (CMO work), technical, and validation support as well as training (5).
Beyond China and India, L…
Article
Bureaucratic Roadblocks Threaten Biopharma Growth
…t millions of Indians face, but that it undermines the nation’s goal of becoming a healthcare and science innovator. There are companies around the world interested in collaborating in research, scie…
Article
Regulation of Biosimilars: A Matter of Variability, Similarity, and Comparability
Joerg Windisch, EBG chair and chief science officer of Sandoz Pharmaceuticals, stressed that comparability between biosimilars and their reference products included having similar variabilities, parti…